PriceSensitive

Neurotech director liable of misconduct

Health Care, The Market Herald
ASX:NTI      MCAP $83.42M
27 March 2019 10:01 (AEST)

Neurotech’s strategic adviser, Dr. Adrian Attard Trevisan, has been found guilty of misconduct after the Malta Times published an article suggesting he never completed a PhD in neuroscience. 

Dr. Adrian Attard Trevisan has admitted to his wrong-doing, stating he mislead the public and has never completed a PhD in Neuroscience, from the University of College London. But instead, Dr. Attard Trevisan has a completed PhD in Human Physiology from the University of Milan.

As a result, Dr. Adrian Attard Trevisan has resigned, as the director of Limited, in June 2018 and no longer has any with the company and its board or management team.

“Neurotech’s flagship product Mente is the result of much more than the work of one person. Neurotech’s dedicated Mente team has worked for many years to create, refine and improve the device and its therapeutic outcomes – and that work continues today, and into the future,” Neurotech International Limited.

Please find announcement attached: https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvTDYD4Qq0yhKZruNwke92GA%3D%3D

Related News